BioNTech SE (BNTX) Leases (2018 - 2025)
Historic Leases for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $235.0 million.
- BioNTech SE's Leases fell 1158.49% to $235.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $235.0 million, marking a year-over-year decrease of 1158.49%. This contributed to the annual value of $265.1 million for FY2024, which is 1492.84% up from last year.
- BioNTech SE's Leases amounted to $235.0 million in Q3 2025, which was down 1158.49% from $253.9 million recorded in Q2 2025.
- In the past 5 years, BioNTech SE's Leases ranged from a high of $276.1 million in Q2 2024 and a low of $142.8 million during Q1 2021
- Moreover, its 5-year median value for Leases was $235.0 million (2025), whereas its average is $237.1 million.
- In the last 5 years, BioNTech SE's Leases skyrocketed by 9179.79% in 2021 and then tumbled by 2180.43% in 2023.
- BioNTech SE's Leases (Quarter) stood at $226.4 million in 2021, then fell by 4.51% to $216.2 million in 2022, then increased by 6.7% to $230.7 million in 2023, then grew by 14.93% to $265.1 million in 2024, then decreased by 11.37% to $235.0 million in 2025.
- Its Leases stands at $235.0 million for Q3 2025, versus $253.9 million for Q2 2025 and $254.5 million for Q1 2025.